Myeloid Sarcoma Involving the Testis in Adults: Clonal Evolution of Acute Myeloid Leukemia. 2022

Meredith M Nichols, and James R Cook, and David S Bosler, and Heesun J Rogers, and John K S S Philip, and Narender R Jogenpally, and Jordan P Reynolds, and Scott Robertson, and Claudiu V Cotta
Robert J. Tomsich Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, OH.

To describe the clinical, histologic, immunophenotypic, and genetic characteristics of myeloid sarcoma (MS) diagnosed in the testes of adults, 3 cases were identified, and information on their presentation, clinical features, treatment, and outcome was retrieved from the medical records. In addition, histologic, immunophenotypic, and molecular characteristics were reviewed. This showed that all patients had a previous history of acute myeloid leukemia (AML), in 2 cases diagnosed >10 years before the testicular lesions. In 1 case, there was bilateral involvement, while in 2, involvement was unilateral. The neoplastic cells showed evidence of cytogenetic/molecular clonal evolution in all cases, 1 of which also had significant immunophenotypic changes. A mutational profile including NPM1 p.Trp288Cysfs*12, IDH1 p.Arg132His NRAS p.Gly12Asp was seen in 2 of the 3 cases. Concurrent bone marrow involvement by a myeloid neoplasm was diagnosed in 2 patients, in 1, there was AML in the second 8% blasts. These patients progressed rapidly after MS and had a dismal outcome. The patient with no concurrent bone marrow disease had a favorable outcome. In conclusion, MS involving the testes of adults is a rare event, and it may represent the clonal evolution of AML.

UI MeSH Term Description Entries
D008297 Male Males
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D009687 Nuclear Proteins Proteins found in the nucleus of a cell. Do not confuse with NUCLEOPROTEINS which are proteins conjugated with nucleic acids, that are not necessarily present in the nucleus. Nucleolar Protein,Nucleolar Proteins,Nuclear Protein,Protein, Nuclear,Protein, Nucleolar,Proteins, Nuclear,Proteins, Nucleolar
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000090243 Nucleophosmin Predominantly localized in the CELL NUCLEOLUS, involved in diverse cellular processes such as ribosome biogenesis, cytoplasmic-nuclear trafficking, centrosome duplication, and regulation of p53. NO38 Protein,Nucleolar Phosphoprotein B23,Nucleolar Protein B23,Nucleophosmid,Numatrin,Phosphoprotein B23, Nucleolus,Protein B23,B23, Nucleolar Phosphoprotein,B23, Nucleolar Protein,B23, Nucleolus Phosphoprotein,B23, Protein,Nucleolus Phosphoprotein B23,Phosphoprotein B23, Nucleolar,Protein B23, Nucleolar,Protein, NO38
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D013737 Testis The male gonad containing two functional parts: the SEMINIFEROUS TUBULES for the production and transport of male germ cells (SPERMATOGENESIS) and the interstitial compartment containing LEYDIG CELLS that produce ANDROGENS. Testicles,Testes,Testicle
D015470 Leukemia, Myeloid, Acute Clonal expansion of myeloid blasts in bone marrow, blood, and other tissue. Myeloid leukemias develop from changes in cells that normally produce NEUTROPHILS; BASOPHILS; EOSINOPHILS; and MONOCYTES. Leukemia, Myelogenous, Acute,Leukemia, Nonlymphocytic, Acute,Myeloid Leukemia, Acute,Nonlymphocytic Leukemia, Acute,ANLL,Acute Myelogenous Leukemia,Acute Myeloid Leukemia,Acute Myeloid Leukemia with Maturation,Acute Myeloid Leukemia without Maturation,Leukemia, Acute Myelogenous,Leukemia, Acute Myeloid,Leukemia, Myeloblastic, Acute,Leukemia, Myelocytic, Acute,Leukemia, Myeloid, Acute, M1,Leukemia, Myeloid, Acute, M2,Leukemia, Nonlymphoblastic, Acute,Myeloblastic Leukemia, Acute,Myelocytic Leukemia, Acute,Myelogenous Leukemia, Acute,Myeloid Leukemia, Acute, M1,Myeloid Leukemia, Acute, M2,Nonlymphoblastic Leukemia, Acute,Acute Myeloblastic Leukemia,Acute Myeloblastic Leukemias,Acute Myelocytic Leukemia,Acute Myelocytic Leukemias,Acute Myelogenous Leukemias,Acute Myeloid Leukemias,Acute Nonlymphoblastic Leukemia,Acute Nonlymphoblastic Leukemias,Acute Nonlymphocytic Leukemia,Acute Nonlymphocytic Leukemias,Leukemia, Acute Myeloblastic,Leukemia, Acute Myelocytic,Leukemia, Acute Nonlymphoblastic,Leukemia, Acute Nonlymphocytic,Leukemias, Acute Myeloblastic,Leukemias, Acute Myelocytic,Leukemias, Acute Myelogenous,Leukemias, Acute Myeloid,Leukemias, Acute Nonlymphoblastic,Leukemias, Acute Nonlymphocytic,Myeloblastic Leukemias, Acute,Myelocytic Leukemias, Acute,Myelogenous Leukemias, Acute,Myeloid Leukemias, Acute,Nonlymphoblastic Leukemias, Acute,Nonlymphocytic Leukemias, Acute
D060965 Clonal Evolution The process of accumulation of genetic and epigenetic changes over time in individual cells and the effect of the changes on CELL PROLIFERATION. Somatic Evolution,Evolution, Clonal,Evolution, Somatic
D023981 Sarcoma, Myeloid An extramedullary tumor of immature MYELOID CELLS or MYELOBLASTS. Granulocytic sarcoma usually occurs with or follows the onset of ACUTE MYELOID LEUKEMIA. Chloroma,Myeloid Sarcoma,Sarcoma, Granulocytic,Extramedullary Myeloid Cell Tumor,Myeloid Cell Tumor, Extramedullary,Chloromas,Granulocytic Sarcoma,Granulocytic Sarcomas,Myeloid Sarcomas,Sarcomas, Granulocytic,Sarcomas, Myeloid

Related Publications

Meredith M Nichols, and James R Cook, and David S Bosler, and Heesun J Rogers, and John K S S Philip, and Narender R Jogenpally, and Jordan P Reynolds, and Scott Robertson, and Claudiu V Cotta
July 1993, Blood,
Meredith M Nichols, and James R Cook, and David S Bosler, and Heesun J Rogers, and John K S S Philip, and Narender R Jogenpally, and Jordan P Reynolds, and Scott Robertson, and Claudiu V Cotta
September 2005, American journal of clinical pathology,
Meredith M Nichols, and James R Cook, and David S Bosler, and Heesun J Rogers, and John K S S Philip, and Narender R Jogenpally, and Jordan P Reynolds, and Scott Robertson, and Claudiu V Cotta
July 2013, Blood,
Meredith M Nichols, and James R Cook, and David S Bosler, and Heesun J Rogers, and John K S S Philip, and Narender R Jogenpally, and Jordan P Reynolds, and Scott Robertson, and Claudiu V Cotta
January 2021, Current opinion in hematology,
Meredith M Nichols, and James R Cook, and David S Bosler, and Heesun J Rogers, and John K S S Philip, and Narender R Jogenpally, and Jordan P Reynolds, and Scott Robertson, and Claudiu V Cotta
May 2019, Nature communications,
Meredith M Nichols, and James R Cook, and David S Bosler, and Heesun J Rogers, and John K S S Philip, and Narender R Jogenpally, and Jordan P Reynolds, and Scott Robertson, and Claudiu V Cotta
December 2019, Genes, chromosomes & cancer,
Meredith M Nichols, and James R Cook, and David S Bosler, and Heesun J Rogers, and John K S S Philip, and Narender R Jogenpally, and Jordan P Reynolds, and Scott Robertson, and Claudiu V Cotta
December 2015, Experimental hematology,
Meredith M Nichols, and James R Cook, and David S Bosler, and Heesun J Rogers, and John K S S Philip, and Narender R Jogenpally, and Jordan P Reynolds, and Scott Robertson, and Claudiu V Cotta
January 2019, Blood cancer journal,
Meredith M Nichols, and James R Cook, and David S Bosler, and Heesun J Rogers, and John K S S Philip, and Narender R Jogenpally, and Jordan P Reynolds, and Scott Robertson, and Claudiu V Cotta
January 2010, TSitologiia i genetika,
Meredith M Nichols, and James R Cook, and David S Bosler, and Heesun J Rogers, and John K S S Philip, and Narender R Jogenpally, and Jordan P Reynolds, and Scott Robertson, and Claudiu V Cotta
December 2021, Leukemia & lymphoma,
Copied contents to your clipboard!